1. A multi‐center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors1. Issue 2 (28th September 2012) Authors: Macy, Margaret E.; Duncan, Tracey; Whitlock, James; Hunger, Stephen P.; Boklan, Jessica; Narendren, Aru; Herzog, Cynthia; Arceci, Robert J.; Bagatell, Rochelle; Trippett, Tanya; Christians, Uwe; Rolla, Katherine; Ivy, S. Percy; Gore, Lia Journal: Pediatric blood & cancer Issue: Volume 60:Issue 2(2013:Feb.) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10‐03). Issue 8 (14th April 2017) Authors: Cooper, Todd M.; Sison, Edward Allan Racela; Baker, Sharyn D.; Li, Lie; Ahmed, Amina; Trippett, Tanya; Gore, Lia; Macy, Margaret E.; Narendran, Aru; August, Keith; Absalon, Michael J.; Boklan, Jessica; Pollard, Jessica; Magoon, Daniel; Brown, Patrick A. Journal: Pediatric blood & cancer Issue: Volume 64:Issue 8(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 1/2 dose‐finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Issue 9 (11th May 2018) Authors: Manley, Peter E.; Trippett, Tanya; Smith, Amy A.; Macy, Margaret E.; Leary, Sarah E.S.; Boklan, Jessica; Cohen, Kenneth J.; Goldman, Stewart; Kilburn, Lindsay B.; Dhall, Girish; Devin, Jeanne; Herzog, Cynthia E.; Partap, Sonia; Fauchet, Floris; Badreddine, Emmy; Bernard, John P.; Chi, Susan N. Journal: Pediatric blood & cancer Issue: Volume 65:Issue 9(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma. Issue 2 (2nd November 2020) Authors: Wright, Karen D.; Yao, Xiaopan; London, Wendy B.; Kao, Pei‐Chi; Gore, Lia; Hunger, Stephen; Geyer, Russ; Cohen, Kenneth J.; Allen, Jeffrey C.; Katzenstein, Howard M.; Smith, Amy; Boklan, Jessica; Nazemi, Kellie; Trippett, Tanya; Karajannis, Matthias; Herzog, Cynthia; Destefano, Joseph; Direnzo, J... Journal: Pediatric blood & cancer Issue: Volume 68:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study. Issue 1 (January 2020) Authors: Geoerger, Birgit; Zwaan, C Michel; Marshall, Lynley V; Michon, Jean; Bourdeaut, Franck; Casanova, Michela; Corradini, Nadège; Rossato, Gianluca; Farid-Kapadia, Mufiza; Shemesh, Colby S; Hutchinson, Katherine E; Donaldson, Francis; Liao, Minlei; Caron, Hubert; Trippett, Tanya Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides. Issue 5 (14th August 2017) Authors: Virmani, Pooja; Levin, Laura; Myskowski, Patricia L.; Flores, Eileen; Marchetti, Michael A.; Lucas, Anna Skripnik; Pulitzer, Melissa; Horwitz, Steven; Trippett, Tanya; Moskowitz, Alison; Querfeld, Christiane Journal: Pediatric dermatology Issue: Volume 34:Issue 5(2017:Sep./Oct.) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Double‐deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors. Issue 5 (14th June 2013) Authors: Lun, Xueqing; Ruan, Yibing; Jayanthan, Aarthi; Liu, David J.; Singh, Anjali; Trippett, Tanya; Bell, John; Forsyth, Peter; Johnston, Randal N.; Narendran, Aru Journal: Molecular oncology Issue: Volume 7:Issue 5(2013:Oct.) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Issue 3 (March 2015) Authors: Moskowitz, Alison J; Schöder, Heiko; Yahalom, Joachim; McCall, Susan J; Fox, Stephanie Y; Gerecitano, John; Grewal, Ravinder; Hamlin, Paul A; Horwitz, Steven; Kobos, Rachel; Kumar, Anita; Matasar, Matthew; Noy, Ariela; Palomba, M Lia; Perales, Miguel-Angel; Portlock, Carol S; Sauter, Craig; Shukl... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Issue 3 (March 2015) Authors: Moskowitz, Alison J; Schöder, Heiko; Yahalom, Joachim; McCall, Susan J; Fox, Stephanie Y; Gerecitano, John; Grewal, Ravinder; Hamlin, Paul A; Horwitz, Steven; Kobos, Rachel; Kumar, Anita; Matasar, Matthew; Noy, Ariela; Palomba, M Lia; Perales, Miguel-Angel; Portlock, Carol S; Sauter, Craig; Shukl... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗